Neonatal Abstinence Syndrome
Minnesota hospitals and health systems have come together to develop new ways to better screen for and treat pregnant women and their newborn babies who are addicted to opioids. Neonatal abstinence syndrome, or NAS, is drug withdrawal that occurs in newborns who were exposed to opioids prior to birth. NAS is on the rise in Minnesota and nationwide.
To help provide a statewide response to the opioid epidemic in pregnant women and newborns, the Minnesota Hospital Association (MHA) convened a work group of obstetricians, perinatalogists and neonatologists to develop tools that hospitals and health systems across the state can now use to identify, assess and treat newborns with NAS and their mothers experiencing opioid addiction.
Resources include a risk assessment tool to help medical professionals identify opioid addiction early during pregnancy, so pregnant women can get appropriate treatment before giving birth; several different newborn assessment tools to help medical professionals identify NAS; and information about NAS treatment options to help hospitals and health systems make decisions about how they will treat NAS. View the toolkit.